Skip to main content
Pharmarise Holdings Corporation logo

Pharmarise Holdings Corporation — Investor Relations & Filings

Ticker · 2796 ISIN · JP3802320006 T Human health and social work activities
Open in API
Filings indexed 84 across all filing types
Latest filing 2026-01-09 Regulatory Filings
Country JP Japan
Listing T 2796

About Pharmarise Holdings Corporation

https://www.pharmarise.com/en/

Pharmarise Holdings Corporation is a holding company that manages and operates a network of dispensing pharmacies. The company's core business involves providing professional pharmaceutical services, primarily dispensing prescription medications to patients based on physicians' orders. Responding to the increasing separation of medical and pharmaceutical practices, Pharmarise focuses on fulfilling the community's need for expert pharmaceutical care. The group aims to enhance local medical services by working closely with community members, patients, and medical institutions. This collaborative approach is central to its strategy of building trust and delivering highly valued medical services, driving growth through a commitment to professional expertise and community integration.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification by the CEO of Pharmarise Holdings Corporation, confirming the accuracy of the contents of a previously filed semi-annual report. Per the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS). H1 40
2026-01-09 Japanese
半期報告書－第40期(2025/06/01－2026/05/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Kanto Local Finance Bureau in Japan. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow analysis for the interim period (June 1, 2025, to November 30, 2025). It follows the regulatory requirements for interim financial reporting under the Financial Instruments and Exchange Act. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. H1 2025
2026-01-09 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. This is a mandatory document filed alongside the Annual Securities Report (Yukashoken Hokokusho) to confirm the accuracy of the report's contents. Since it is a regulatory filing required by law that does not fit into the specific categories of financial reports, earnings releases, or announcements, it falls under the 'Regulatory Filings' (RNS) category. FY 2025
2025-08-25 Japanese
有価証券報告書－第39期(2024/06/01－2025/05/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains a formal header identifying it as a filing under the Financial Instruments and Exchange Act, specifies the fiscal year (39th period), and includes XBRL-like metadata tags typical of comprehensive annual financial disclosures. It is not an announcement or a summary, but the full report itself. FY 2025
2025-08-25 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document header explicitly states the filing type as "自己株券買付状況報告書" (Report on the Status of Treasury Stock Acquisition). The legal basis cited is Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act. The content details the acquisition status of treasury stock (自己株式) during the reporting period (January 1 to January 31, 2025), including the total number of shares acquired and the remaining balance. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2025-02-07 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is extremely short (600 chars) and appears to be a confirmation document ('確認書') related to a financial filing. Key phrases include '半期報告書' (Half-Year Report), '第39期中（自 令和６年６月１日 至 令和６年11月30日）' (Fiscal period details), and confirmation by the CEO that the content is appropriate under financial instruments law. Since this is a confirmation *about* a Half-Year Report, and not the comprehensive report itself, it strongly suggests an announcement or supplementary document related to the filing. Given the context of a confirmation related to a '半期報告書' (Interim/Quarterly Report), and the document being a short confirmation rather than the full report, it is most likely a Regulatory Filing (RNS) or potentially related to the Interim Report (IR). However, because it is a specific confirmation document ('確認書') required by law regarding the accuracy of the Interim Report, and not the report itself, RNS is the most appropriate general regulatory fallback, although IR is closely related. Given the structure, it is a specific regulatory confirmation, fitting best under RNS as a miscellaneous regulatory filing that isn't the core report.
2025-01-10 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.